1. C. elegans: a novel pharmacogenetic model to study Parkinson's disease. Nass R, Miller DM, Blakely RD (2001) Parkinsonism Relat Disord 7(3): 185-191
    › Primary publication · 11331185 (PubMed)
  2. Autocrine regulation of norepinephrine transporter expression. Ren ZG, Pƶrzgen P, Zhang JM, Chen XR, Amara SG, Blakely RD, Sieber-Blum M (2001) Mol Cell Neurosci 17(3): 539-50
    › Primary publication · 11273648 (PubMed)
  3. Ultrastructural localization of the serotonin transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to dopamine terminals. Miner LH, Schroeter S, Blakely RD, Sesack SR (2000) J Comp Neurol 427(2): 220-34
    › Primary publication · 11054690 (PubMed)
  4. SNARE-ing neurotransmitter transporters. Blakely RD, Sung U (2000) Nat Neurosci 3(10): 969-71
    › Primary publication · 11017164 (PubMed)
  5. Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. Shannon JR, Flattem NL, Jordan J, Jacob G, Black BK, Biaggioni I, Blakely RD, Robertson D (2000) N Engl J Med 342(8): 541-9
    › Primary publication · 10684912 (PubMed)
  6. Molecular cloning of a human, hemicholinium-3-sensitive choline transporter. Apparsundaram S, Ferguson SM, George AL, Blakely RD (2000) Biochem Biophys Res Commun 276(3): 862-7
    › Primary publication · 11027560 (PubMed)
  7. Modified structure of the human serotonin transporter promoter. Flattem NL, Blakely RD (2000) Mol Psychiatry 5(1): 110-5
    › Primary publication · 10673778 (PubMed)
  8. Immunolocalization of the cocaine- and antidepressant-sensitive l-norepinephrine transporter. Schroeter S, Apparsundaram S, Wiley RG, Miner LH, Sesack SR, Blakely RD (2000) J Comp Neurol 420(2): 211-32
    › Primary publication · 10753308 (PubMed)
  9. Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A. Bauman AL, Apparsundaram S, Ramamoorthy S, Wadzinski BE, Vaughan RA, Blakely RD (2000) J Neurosci 20(20): 7571-8
    › Primary publication · 11027216 (PubMed) · PMC6772869 (PubMed Central)
  10. Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells. Rakhshan F, Day TA, Blakely RD, Barker EL (2000) J Pharmacol Exp Ther 292(3): 960-7
    › Primary publication · 10688610 (PubMed)